Market Powers Throu...
Health Care: Drugs
Par Pharmaceutical Companies Inc. (PRX: NYSE)
$39.54 -0.07 | -0.18%
05/24/12 - 04:02 PM ET
245.28K / 317.60K
Vol / Avg. Vol:39.48 / 39.61
Open / Prev. Close:39.19 - 39.69
Today's Range:24.85 - 42.80
52 Wk Range:20.81%
Performance YTD:TheStreet Rating:
Portfolios with PRX
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 9
- Contributor8 Pharma Stocks to Watch
- Contributor10 Health Care Stocks With ...
- Contributor10 Pharma Stocks With Upside
- UserBlue Star
- UserDavid Maxwell Portfolio 1
- UserPART 6 JPMorgan 28th Annual...
- UserMillion Contrarian
- Userkern44 Portfolio 1
- UserSUPRATRADE-0303071618
Latest PRX Headlines from TheStreet
- Par Pharma CEO: Double-Digit Growth
05.01.12 | 05:05 am - Par Pharmaceutical Companies Stock Hits New 52-Week High (PRX) 04.27.12 | 10:04 am
- WCG, CL, SJM, PRX Hit 52-Week Highs 03.30.12 | 11:03 am
- Par Pharmaceutical Companies Reaches New 52-Week High (PRX) 03.30.12 | 09:03 am
- Par Pharmaceutical Companies Reaches New 52-Week High (PRX) 02.01.12 | 02:02 pm
- UBS: 8 Pharma Stocks to Watch 01.20.12 | 12:01 pm
- Par Pharmaceutical Companies Stock Hits New 52-Week High (PRX) 01.19.12 | 01:01 pm
- Par Pharmaceutical Companies Inc. Stock Upgraded (PRX) 01.13.12 | 06:01 am
- Par Pharmaceutical Companies Stock Hits New 52-Week Low (PRX) 09.22.11 | 12:09 pm
- Par Pharmaceutical Companies Stock Hits New 52-Week Low (PRX) 09.06.11 | 03:09 pm
Press Releases for PRX
- Par Pharmaceutical Acquires Rights To Market And Distribute Generic Dexilant® In The U.S. - PR Newswire 04.19.12 | 03:04 pm
- Par Pharmaceutical Begins Shipment Of Generic Provigil® - PR Newswire 04.06.12 | 07:04 am
- Par Pharmaceutical Completes Acquisition Of Edict Pharmaceuticals - PR Newswire 02.17.12 | 04:02 pm
- Par Pharmaceutical Companies To Report Fourth Quarter And Full Year 2011 Results On February 28, 2012 - PR Newswire 01.31.12 | 09:01 am
- Par Pharmaceutical To Host Analyst Day On January 6, 2012 - PR Newswire 12.05.11 | 09:12 am
- Par Pharmaceutical Companies Promotes Thomas J. Haughey To President And Paul V. Campanelli To Chief Operating Officer - PR Newswire 11.22.11 | 08:11 am
- Par Pharmaceutical Completes Acquisition Of Anchen - PR Newswire 11.17.11 | 12:11 pm
- Par Pharmaceutical Begins Shipment Of Generic Zyprexa® Zydis® - PR Newswire 10.24.11 | 03:10 pm
- Par Pharmaceutical Acquires Three Generic Products From Teva Pharmaceuticals - PR Newswire 10.18.11 | 09:10 am
- Par Pharmaceutical Files Declaratory Judgment To Protect First Amendment Rights To Disseminate Truthful Information Regarding Megace® ES - PR Newswire 10.14.11 | 04:10 pm
Partner Headlines for PRX
- Par Pharmaceuticals Companies, Inc. - Value - Zacks 05.15.12 | 01:05 am
- Par Pharma Acquires Handa's ANDA - Analyst Blog - Zacks 04.20.12 | 07:04 am
- PRX Outperforms; Reaffirms Guidance - Analyst Blog - Zacks 03.05.12 | 09:03 am
- EPS, Revenues Decline at Par Pharma - Analyst Blog - Zacks 11.04.11 | 04:11 pm
- Company News for October 21, 2011 - Corporate Summary - Zacks 10.21.11 | 10:10 am
- Stocks Rebound, Trade Higher Amid Mixed Slate of Earnings; China Data Weighs - NASDAQ 10.18.11 | 04:10 pm
- Mid-Day Update: Stocks Shift Higher After Mixed Start; China, Earnings Weigh - NASDAQ 10.18.11 | 04:10 pm
- Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES - Benzinga 10.14.11 | 04:10 pm
- Emisphere: Crown Jewel In Oral B12 - Seeking Alpha 10.07.11 | 09:10 am
- Par Pharma Targets Anchen Pharma - Analyst Blog - Zacks 08.25.11 | 10:08 am
